INSULINREZEPTOR-BINDENDE ANTIKÖRPER

European patent · EP2480254 · In force

Register entry

Publication number
EP2480254
Application number
EP10766418
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 25, 2010
Published
Aug 1, 2012
Granted
Jan 13, 2016
Protection ends at the latest
Sep 24, 2030
Next annual fee due
Sep 30, 2027
IPC classes
A61K 39/395 (2006.01)
A61P 3/10 (2006.01)
C07K 16/26 (2006.01)
C07K 16/28 (2006.01)
Priority
US 306321 P 19.02.2010
US 246067 P 25.09.2009
US 358749 P 25.06.2010
PCT application
PCT/US2010/050313 25.09.2010
PCT publication
WO2011/038302 31.03.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  4. Oct 2, 2023

    Change

    Published in Swissreg on 02.10.2023

  5. Oct 6, 2022

    Change

    Published in Swissreg on 06.10.2022

  6. Jan 13, 2016

    Granted

    Published in Swissreg on 13.01.2016

Parties

Holder

XOMA (US) LLC

2910 Seventh Street, Berkeley, CA 94710, US

Inventor

WHITE, Mark, Leslie

Berkeley, CA 94710, US

WATSON, Susan, R.

Berkeley, CA 94710, US

BHASKAR, Vinay

Berkeley, CA 94710, US

CORBIN, John

Berkeley, CA 94710, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.